Recently, emerging evidence indicates that IRE1α signaling can also control UPR-independent cellular pathways, influencing processes such as hepatic lipogenesis, angiogenesis, atherosclerosis, arthritis, and antitumor immunity [28–32]. This evidence concerns the gene ERN1 and arthritic joint disease.